DUBLIN, Dec. 19, 2016 /PRNewswire/ -- Endo International plc (NASDAQ / TSX: ENDP) announced today that Paul Campanelli, President and CEO, is scheduled to present at the 35^th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9, 2017 at 10:30 a.m. PST / 1:30 p.m. EST.

A live webcast and audio archive for the event will be available on the Company's website at http://www.endo.com/investors/overview. Participants should allow approximately 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo International plc

Endo International plc (NASDAQ / TSX: ENDP) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300379905.html

SOURCE Endo International plc

Endo International plc: Investors/Media: Stephen Mock, (845) 364-4833; Media: Heather Zoumas-Lubeski, (484) 216-6829; Investors: Nina Goworek, (484) 216-6657